Marta Monari
Papers
1
Total Citations
6
H-Index
1
About
Dr. Marta Monari is a leading clinical researcher in urological oncology, with a focused expertise in prostate cancer diagnostics and post-surgical monitoring. Her work centers on improving the early detection of biochemical recurrence (BCR) following radical prostatectomy, a critical challenge in managing prostate cancer. Her most cited study, a 2019 observational prospective cohort, demonstrated that the biomarker p2PSA can predict BCR significantly earlier than traditional total prostate-specific antigen (PSA) testing. This contribution addresses an unmet clinical need for more sensitive, specific tests to identify clinically significant recurrent disease at a stage when intervention may be most effective. With 6 citations, this work has already informed ongoing discussions in precision oncology and biomarker-guided surveillance. Dr. Monari’s research bridges the gap between molecular biomarkers and real-world clinical outcomes, offering patients and clinicians a more proactive tool for post-treatment monitoring. Her dedication to advancing prostate cancer care underscores her role as a key contributor to the evolving landscape of urological cancer management.
Research Focus
Key Achievements
Top Papers
- 1